+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Tafinlar - API Insight, 2022

  • PDF Icon

    Drug Pipelines

  • 30 Pages
  • January 2022
  • Region: Global
  • DelveInsight
  • ID: 4330875
UP TO OFF until Dec 31st 2024
"Tafinlar - API 2022" report by the publisher provides product and API manufacturers details across US, Europe, China and India for Tafinlar . It includes Tafinlar overview, mechanism, regulatory milestones, deals & partnerships, clinical trials and other development activities. It further provides Tafinlar's patents information (US & EU). It also features the historical and forecasted sales of Tafinlar 2024. The report also highlights Tafinlar's market competition and emerging therapies which are in the same space as Tafinlar

Methodology


Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by the publisher's team of industry experts. Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

Scope of the Report


A comprehensive product overview including product description, regulatory milestones, safety, pharmacological properties, clinical trials, and product development activities have been elaborated in this report
Patent information around Tafinlar in United States (US) and Europe (EU) has been highlighted
API manufacturers for Tafinlar in United States, Europe, China and India
The report contains historical and forecasted sales for Tafinlar 2024
Enlists the market competition and emerging therapies in the space where Tafinlar operates

Reasons to Buy


Establish a comprehensive understanding of the drug, Tafinlar
Access to Tafinlar's API manufacturers details to devise API procurement strategy for generic development
Plan generic developmental timelines around Tafinlar's patents for the major markets- US and EU
Understand Tafinlar's current and future growth through its historical and forecasted sales
Identify the current in-market competitors for Tafinlar
Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
Identify the emerging players and their products operating in the same space as Tafinlar.

Table of Contents

1. Report Introduction
2. Tafinlar Overview
  • Product Description
  • Mechanism of Action
  • Dosage and Administration
  • Pharmacodynamic Properties
  • Pharmacokinetic Properties
  • Safety and Efficacy of Tafinlar
  • Clinical Trial Description
  • Adverse Reactions
  • Product Development Activities

3. Product Details
  • United States
  • Europe

4. Tafinlar Global Sales Assessment
  • Historical Global Sales
  • Forecasted Global Sales

5. Patent Details
6. Global API Manufacturers Assessment
  • United States
  • Europe
  • China
  • India

7. Market Competitors8. Emerging Therapies
9. Appendix
  • Methodology
  • Consulting Services
  • About the Publisher
  • Contact Us
  • Disclaimer

List of Tables
Table 1: Tafinlar Description
Table 2: Tafinlar Product Details, United States
Table 3: Tafinlar Product Details, Europe
Table 4: Tafinlar , Historical Global Sales till 2021 (in million USD)
Table 5: Tafinlar , Forecasted Global Sales from 2022-2024 (in million USD)
Table 6: Patent Details: Tafinlar
Table 7: API Manufacturers Region wise
Table 8: API Manufacturers for United States
Table 9: API Manufacturers for Europe
Table 10: API Manufacturers for China
Table 11: API Manufacturers for India
Table 12: Tafinlar Market Competitors
Table 13: Emerging Therapies
List of Figures
Figure 1: Tafinlar
Figure 2: Tafinlar , Historical Global Sales till 2017 (in million USD)
Figure 3: Tafinlar , Forecasted Global Sales from 2020-2022 (in million USD)
Figure 4: Patent Details: Tafinlar
Figure 5: API Manufacturers Region wise
Figure 6: Patent Details: Tafinlar
Figure 7: API Manufacturers Region wise
Figure 8: API Manufacturers for United States
Figure 9: API Manufacturers for Europe
Figure 10: API Manufacturers for China
Figure 11: API Manufacturers for India
Figure 12: Tafinlar Market Competitors
Figure 13: Emerging Therapies